The company reported total revenue growth of 8% at constant exchange rates for the third quarter of fiscal 2025, and confirmed its guidance for the year.
Related Posts
Financial Services Roundup: Market Talk
Find insight on HSBC, Munich Re and more in the latest Market Talks covering financial services.
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
The genetics company is closing a unit that was once seen as core to its future.
Tussle for Control of Korea Zinc Sends Shares Higher
Shares of the Seoul-based nonferrous-metal producer closed 8.8% higher, outperforming the benchmark Kospi’s 0.3% gain.